Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver Kepp

Showing results (81-90 of 364) with videos related to

Pageof 37
Sort By:
Biology Direct|November 1, 2023
Conventional type 1 dendritic cells (cDC1) in cancer immunityPeng Liu, Liwei Zhao, Guido Kroemer, et al.
Methods in Enzymology|February 1, 2020
Quantitation of calreticulin exposure associated with immunogenic cell deathPeng Liu, Liwei Zhao, Oliver Kepp, et al.
Oncoimmunology|May 31, 2019
Crizotinib - a tyrosine kinase inhibitor that stimulates immunogenic cell deathPeng Liu, Liwei Zhao, Oliver Kepp, et al.
Oncoimmunology|July 12, 2025
How macrophages use extracellular calreticulin to chase their preyLiwei Zhao, Peng Liu, Oliver Kepp, et al.
Nature Reviews. Immunology|November 7, 2024
The danger theory of immunity revisitedGuido Kroemer, Léa Montégut, Oliver Kepp, et al.
Oncoimmunology|April 7, 2026
Pharmacological inhibition of MAPK P38α rescues the immune defect of dendritic cells affected by the FPR1 loss-of-function polymorphism rs867228Liwei Zhao, Oliver Kepp, Peng Liu, et al.
Oncoimmunology|October 10, 2022
Nanoparticles releasing immunogenic cell death inducers upon near-infrared light exposureOliver Kepp, Giulia Cerrato, Allan Sauvat, et al.
Oncoimmunology|October 20, 2023
A mitochondrial checkpoint to adaptive anticancer immunityOliver Kepp, Peng Liu, Guido Kroemer, et al.
Nature Reviews. Clinical Oncology|October 10, 2019
Oncolysis without viruses - inducing systemic anticancer immune responses with local therapiesOliver Kepp, Aurelien Marabelle, Laurence Zitvogel, et al.
Current Biology : CB|February 11, 2010
Bacterial invasion: linking autophagy and innate immunityLorenzo Galluzzi, Oliver Kepp, Laurence Zitvogel, et al.
Pageof 37

Showing results (81-90 of 364) with videos related to

Sort By:
Pageof 37
Biology Direct|November 1, 2023
Conventional type 1 dendritic cells (cDC1) in cancer immunityPeng Liu, Liwei Zhao, Guido Kroemer, et al.
Methods in Enzymology|February 1, 2020
Quantitation of calreticulin exposure associated with immunogenic cell deathPeng Liu, Liwei Zhao, Oliver Kepp, et al.
Oncoimmunology|May 31, 2019
Crizotinib - a tyrosine kinase inhibitor that stimulates immunogenic cell deathPeng Liu, Liwei Zhao, Oliver Kepp, et al.
Oncoimmunology|July 12, 2025
How macrophages use extracellular calreticulin to chase their preyLiwei Zhao, Peng Liu, Oliver Kepp, et al.
Nature Reviews. Immunology|November 7, 2024
The danger theory of immunity revisitedGuido Kroemer, Léa Montégut, Oliver Kepp, et al.
Oncoimmunology|April 7, 2026
Pharmacological inhibition of MAPK P38α rescues the immune defect of dendritic cells affected by the FPR1 loss-of-function polymorphism rs867228Liwei Zhao, Oliver Kepp, Peng Liu, et al.
Oncoimmunology|October 10, 2022
Nanoparticles releasing immunogenic cell death inducers upon near-infrared light exposureOliver Kepp, Giulia Cerrato, Allan Sauvat, et al.
Oncoimmunology|October 20, 2023
A mitochondrial checkpoint to adaptive anticancer immunityOliver Kepp, Peng Liu, Guido Kroemer, et al.
Nature Reviews. Clinical Oncology|October 10, 2019
Oncolysis without viruses - inducing systemic anticancer immune responses with local therapiesOliver Kepp, Aurelien Marabelle, Laurence Zitvogel, et al.
Current Biology : CB|February 11, 2010
Bacterial invasion: linking autophagy and innate immunityLorenzo Galluzzi, Oliver Kepp, Laurence Zitvogel, et al.
Pageof 37